The role of systemic chemotherapy and optimal regimen in thymic carcinoma remains
uncertain. We evaluated the clinical responsiveness of ADOC (cisplatin, doxorubicin …

BACKGROUND Thymic carcinoma is a rare neoplasm that often disseminates or
metastasizes. The role of chemotherapy in treating this malignancy is unclear. The purpose …

Background The prognostic factors and the efficacy of first‐line chemotherapy remain
unclear in patients with advanced thymic carcinoma. Materials and Methods We conducted …

Background: Optimal chemotherapeutic regimen in thymic carcinoma remains uncertain and
the efficacy of second line chemotherapy has not been established either. Patients and …

Introduction: Thymic carcinoma is a rare epithelial neoplasm that tends to be aggressive and
metastasize widely. The optimal chemotherapy for unresectable advanced thymic carcinoma …

Background: Thymic carcinoma has a dismal prognosis compared with thymoma, because
most of such tumors have locoregional invasion when diagnosed. Thus the important step in …

Objectives: The aim of this study is to retrospectively evaluate the role of several therapies,
mainly chemotherapy, for thymic carcinoma (TC). Methods: From July 1973 to July 2005, 25 …

Objective Thymic carcinoma is a rare cancer of the thymus, different from thymoma in
respect of its malignant nature, and no standard chemotherapy for this cancer has been …

The optimal chemotherapeutic regimen for thymic carcinoma remains uncertain and the
utility of salvage therapy has also not been reported. Three cases of unresectable and …

Background: Thymic carcinoma is a rare mediastinal neoplasm with poor prognosis.
Although the clinical benefit of chemotherapy for thymic carcinoma is controversial, cisplatin …